is semaglutide off patent Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely? On March 20, 2026, the protecting Novo Nordisk's expired in India. Within 24 hours, the market transformed. Leading pharmaceutical giants Novo Nordisk Settles Ozempic Patent

The drug regulator has asked the state authorities to ensure that manufacture/import, distribution, retail/wholesale sales, and dispensing occur only through authorised channels and strictly in line with approved indications and labelling, in an advisory dated March 27

For those searching for options like "Ozempic clinic near you," however, at Klinic, we ensure you receive treatments specifically approved for weight loss, enhancing insurance approval odds

Review of Phase II applications submitted in September 2025 was paused during the lapse in SBIR/STTR authorization

Oral semaglutide (Rybelsus) represents another option, though gastrointestinal side effects remain prevalent with this formulation